Evidence map›Paper›PMID 30302062›Full record

ArticleGastroenterology & hepatology2018

Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

Stephanie L Gold, Shirley Cohen-Mekelburg, Yecheskel Schneider, Adam Steinlauf

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology & hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Management of Enterocutaneous Fistula: A Review.JNMA; journal of the Nepal Medical Association · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Maneuvering Clinical Pathways for Crohn's Disease.Current gastroenterology reports · 2019
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Stephanie L GoldDr Gold is an internal medicine resident in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.
Shirley Cohen-MekelburgDr Gold is an internal medicine resident in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.
Yecheskel SchneiderDr Gold is an internal medicine resident in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.
Adam SteinlaufDr Gold is an internal medicine resident in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.
Cornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant advances in the treatment of luminal inflammatory bowel disease, the treatment of perianal fistulas remains a clinical challenge. Perianal fistulas are traditionally described using the Parks classification based on their relationship to the external and internal anal sphincters. Traditional therapy for perianal fistulas focuses on antibiotics such as metronidazole or ciprofloxacin. However, medical management has expanded over the years to include immunomodulators and, most recently, biologic agents. Newer techniques such as intrafistulous biologic injections are also being explored as potentially effective treatments for patients with fistulizing disease. Here, in the first of a 2-part series on perianal fistulas in patients with Crohn's disease, we discuss the anatomy and classification of perianal fistulas as well as current medical therapies, including antibiotics, immunomodulators, biologic agents, and novel therapeutic agents. The second part of the series will focus on the surgical modalities that are available for patients with perianal fistulas in addition to novel endoscopic techniques and future therapies that are being investigated for the treatment of fistulizing Crohn's disease.

Indexed as

biologic agentsCrohn’s diseasefistulaimmunomodulatorsPerianal disease

Identifiers

PMID30302062
PMCPMC6170888
OpenAlexW2896919713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.